Get the Stockscreener App
6.17
161.44%
3.81
After Hours:
5.93
-0.24
-3.89%
Cervomed Inc Stock (CRVO) Latest News
Chardan lifts CervoMed stock rating to Buy, targets $14 - Investing.com India
CervoMed upgraded to Buy from Neutral at Chardan - TipRanks
Washington Post columnist who resigned over a spiked Bezos op-ed ‘fears’ readers can’t trust opinion writers - CNN
Flying is getting worse, if you can believe it - CNN
EU's tariffs will be 'devastating' for spirits sector, industry says - info-mods.com
The maker of Roomba has ‘substantial doubt’ about surviving - CNN
CervoMed (NASDAQ:CRVO) Given New $15.00 Price Target at Roth Mkm - Defense World
CervoMed Inc.'s (NASDAQ:CRVO) Price Is Right But Growth Is Lacking - Simply Wall St
China's commerce ministry meets with Walmart on supplier pricing, state media says - Yahoo Finance
CervoMed’s (CRVO) Buy Rating Reaffirmed at D. Boral Capital - Defense World
CervoMed Shares Business and Financial Updates Online - TipRanks
Ontario premier threatens to ‘shut off electricity completely’ for US if trade war escalates - CNN
Brookline raises CervoMed stock rating to buy, sets $16 target - Investing.com
Mineralys aims to raise $250M; Coherus discloses layoffs - Endpoints News
Brookline raises CervoMed stock rating to buy, sets $16 target By Investing.com - Investing.com UK
Trump administration backs off mandate addressing housing segregation and discrimination - CNN
Trump says he’ll buy a Tesla to support Elon Musk, whose companies are struggling - CNN
Brookline Capital Upgrades CervoMed to Buy From Hold, Price Target is $16 -March 11, 2025 at 08:46 am EDT - Marketscreener.com
CervoMed price target raised to $15 from $7 at Roth MKM - TipRanks
CervoMed reports positive results from dementia trial - The Pharma Letter
Dementia drug neflamapimod shows positive phase 2b trial results - PharmaTimes
What Trump actually wants from tariffs - CNN
Who is Mark Carney, the crisis-handling former central bank governor turned Canada’s next leader? - CNN
China unveils big plan to fix its ailing economy and transform into a high-tech power - CNN
CervoMed announces results from extension phase of RewinD-LB study - TipRanks
CervoMed Reports Positive Phase 2b Trial Results - TipRanks
CervoMed Inc. Reports Positive Results from Extension Phase of Phase 2b RewinD-LB Study for Neflamapimod in Dementia with Lewy Bodies - Nasdaq
CervoMed Announces Positive Results from the Extension - GlobeNewswire
CVS is opening smaller stores that only have pharmacies - CNN
Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints - Yahoo Finance
Analysts Set CervoMed Inc. (NASDAQ:CRVO) PT at $37.43 - Defense World
Here's Why Associated Banc-Corp (ASB) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
7-Eleven’s Japanese owner appoints American CEO to fend off $47 billion takeover bid - CNN
Walgreens is going private in an up to $24 billion deal - CNN
Camping World Holdings' (NYSE:CWH) Dividend Will Be $0.125 - Yahoo Finance
The US Postal Service is more efficient than you think. Privatizing it could cause problems for many - CNN
Musk’s Starlink gets FAA contract, raising new conflict of interest concerns - CNN
MSNBC announces major lineup overhaul, new Washington bureau as Joy Reid exits company - CNN
CervoMed (NASDAQ:CRVO) Raised to Buy at D. Boral Capital - Armenian Reporter
Why VNET Group, Inc. (VNET) Went Up On Thursday? - Yahoo Finance
Boral Capital raises CervoMed stock to Buy, sets $10 target By Investing.com - Investing.com Australia
Why CervoMed (CRVO) Is Advancing Today - Yahoo Canada Finance
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Boral Capital raises CervoMed stock to Buy, sets $10 target - Investing.com
How Are Things Looking For CervoMed Inc (NASDAQ: CRVO) For The Short Term? - Stocks Register
Why VNET Group, Inc. (VNET) Soared Last Week - Yahoo Finance
CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average PT from Brokerages - Defense World
Why Millrose Properties Inc. (MRP) Went Down on Monday - Yahoo Finance
Perigon Wealth Management LLC Makes New Investment in CervoMed Inc. (NASDAQ:CRVO) - Defense World
CervoMed Provides Update on Neflamapimod DLB Program as - GlobeNewswire
CervoMed reports progress in dementia drug trial - MSN
CervoMed Updates on Neflamapimod Trials for Dementia - TipRanks
CervoMed reports progress in dementia drug trial By Investing.com - Investing.com UK
Clinical Trial Setback: CervoMed's Dementia Drug Gets Second Chance with Enhanced Formula - StockTitan
CervoMed to Present at the 8th International Lewy Body Dementia Conference - GlobeNewswire
Major Breakthrough in Lewy Body Dementia Treatment: CervoMed Reveals Game-Changing Clinical Data - StockTitan
CervoMed Inc. (NASDAQ:CRVO) Stock Holdings Lifted by Barclays PLC - Defense World
Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - Yahoo Finance
Roth MKM Initiates Coverage of CervoMed (CRVO) with Buy Recommendation - MSN
CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average Price Target from Analysts - Defense World
AWM Investment Company, Inc. Reduces Stake in CervoMed Inc - GuruFocus.com
CervoMed (STU:DP8) Momentum Rank : 8 (As of Jan. 11, 2025) - GuruFocus.com
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):